Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 4, 1986
Grant Date -
N/A
app pub date -
Oct 9, 1984
filing date -
Oct 9, 1984
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A method for transdermal delivery of naloxone, naltrexone and nalbuphine base through intact skin is described. Preferred embodiments of transdermal therapeutic systems for delivering these drugs and polyethylene glycol monolaurate employ an ethylene vinylacetate matrix containing drug base at a concentration above saturation and polyethylene glycol monolaurate below unit activity. Polyethylene glycol manolaurate is disclosed as a permeation enhancer for the base form of these drugs and is preferably delivered simultaneously with the drug.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully